About
Developing a family of biodegradable, sustained-release drug delivery implants (Epidel platform) for glaucoma and other chronic eye conditions.
HQ: Toronto, Canada
Funding
VC-backed; pursuing financing for Phase 2
—Company profile
Epidel — biodegradable sustained-release implants for glaucoma and other eye disease.
Developing a family of biodegradable, sustained-release drug delivery implants (Epidel platform) for glaucoma and other chronic eye conditions.
HQ: Toronto, Canada